REIMAGINING ANTIBODY MEDICINES
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Aug 2025)
What this means for you
This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97846922
- Mark type
- Stylized text
- Filed
- 20 Mar 2023
- Published for opposition
- 19 Nov 2024
- Abandoned
- 04 Aug 2025
- Attorney of record
- Karen Feisthamel
Goods and services
- Class 036 — Insurance and financial services: Providing financial and investment information in the field of antibodies and antibody research and development
- Class 041 — Education and entertainment services: Education services, namely, arranging and conducting educational congresses in the field of antibodies and antibody research and development
Owner
- IGM Biosciences, Inc., Mountain View, CA, US
- IGM Biosciences, Inc., Mountain View, CA, US
Prosecution history
- 04 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Oct 2024 — ASSIGNED TO LIE
- 10 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 11 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Dec 2023 — NON-FINAL ACTION E-MAILED